Send us a text🧠 Background:RSV causes significant morbidity/mortality in older adults.Previously considered a pediatric virus only.📈 Epidemiology:Hospitalization rate:91/100,000 (ages 64–74).738/100,000 in assisted living patients.💉 Vaccine Update:CDC now recommends RSV vaccine for:All ≥75 years old.60–74 years with chronic conditions (lung, kidney, diabetes with organ damage).Efficacy: 71–80%, wanes to ~50% by 19 months.⚠️ Considerations:Possible risk of Guillain-Barré — ongoing surveillance.Only one dose needed (no boost from second shot yet).🧩 Clinical Takeaway:Strongly recommend for frail seniors and those in communal living.Shared decision-making still advised for those age 60–74.

Ver todos los episodios